Study Of MK-0752 In Combination With Tamoxifen Or Letrozole to Treat Early Stage Breast Cancer
NCT00756717
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
22
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
MK-0752
Sponsor
Loyola University
Collaborators
[object Object]